Literature DB >> 2660582

Etiology of otospongiotic sensorineural losses.

J R Causse1, J B Causse, P Bretlau, J Uriel, J Berges, L G Chevance, G E Shambaugh, J M Bastide.   

Abstract

The etiology of otospongiotic-otosclerotic disease is enzymatic; the proteolytic enzymes released by the otospongiotic-otosclerotic foci damage the inner ear and are also the basis of the bony rebuilding of the OW niche leading to stapedial fixation. The trigger may be an autoimmune process due to the reaction of the enchondral otic capsule against the embryonic cartilaginous remnants, genetically determined to be located in the otic capsule and mainly in the fissula antefenestram.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2660582

Source DB:  PubMed          Journal:  Am J Otol        ISSN: 0192-9763


  5 in total

1.  Further hearing loss during osteoporosis treatment with etidronate.

Authors:  S Yaşil; A Cömlekçi; A Güneri
Journal:  Postgrad Med J       Date:  1998-06       Impact factor: 2.401

2.  Diagnostic efficacy and therapeutic impact of computed tomography in the evaluation of clinically suspected otosclerosis.

Authors:  Cristina Dudau; Fakhruddin Salim; Dan Jiang; Steve E J Connor
Journal:  Eur Radiol       Date:  2016-06-30       Impact factor: 5.315

3.  Does Otosclerosis Affect Dark and Transitional Cells in the Human Vestibular Labyrinth?

Authors:  Serdar Kaya; Michael M Paparella; Sebahattin Cureoglu
Journal:  Otol Neurotol       Date:  2017-02       Impact factor: 2.311

4.  The detrimental effect of aminohydroxypropylidene bisphosphonate (APD) in otospongiosis.

Authors:  L J Boumans; R M Poublon
Journal:  Eur Arch Otorhinolaryngol       Date:  1991       Impact factor: 2.503

Review 5.  Bisphosphonate therapy in otosclerosis: A scoping review.

Authors:  René E Zimmerer; Robert E Africa; Zack K Westenhaver; Brian J McKinnon
Journal:  Laryngoscope Investig Otolaryngol       Date:  2022-01-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.